PG17 Asthma phenotyping

Postgraduate Course
Chairs: A. Spanevello (Milan, Italy), I. Adcock (London, United Kingdom)
Aims: Access educational materials here
to present the innovations in asthma stratification that facilitate personalised therapeutic strategies; to highlight the importance of stratifying asthma patients for selecting the correct therapeutic approaches; to explain the importance of both clinical and biomarker assessment in patient stratification; and to indicate the value of molecular stratification for understanding disease-driving mechanisms and how this may translate to new therapies, particularly for non-Type 2 (T2) asthma.

The need for asthma phenotyping S. Saglani (London, United Kingdom)
Biomarker-high patients and steroid responsiveness P. Gibson (Newcastle, Australia)
Group assignment S. Saglani (London, United Kingdom), P. Gibson (Newcastle, Australia)
Unbiased approaches to asthma stratification - the road to novel therapies P. Sterk (Amsterdam, Netherlands)
Patient stratification and targeted drug therapy - T2 asthma and beyond P. Nair (Hamilton (ON), Canada)